Personalized Medicine Biomarkers Market Size, Share & Trends Report

Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Application (Early Detection, Diagnostics), By Indication (Oncology, Neurology), By Test Location, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-996-3
  • Number of Report Pages: 130
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2020
  • Forecast Period: 2022 - 2030 
  • Industry: Healthcare

Market Segmentation 

  • Personalized Medicine Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Early Detection/Screening
    • Diagnosis
    • Treatment Selection
    • Monitoring
  • Personalized Medicine Biomarkers Indication Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
      • By Type
        • Breast Cancer
        • Lung Cancer
        • Colon Cancer
        • Others
      • By Circulating Biomarkers
        • Circulating Tumor Cells (CTCs)
        • Circulating Cell-free DNA (cfDNA)
        • Extracellular Vesicles (EVs)
        • Other Circulating Biomarkers
    • Neurology
    • Diabetes
    • Autoimmune Diseases
    • Cardiology
    • Others
  • Personalized Medicine Biomarkers Regional Outlook (Revenue, USD Million, 2018- 2030)
    • North America
      • North America Cardiac Biomarkers Market, By Application
        • Early Detection/Screening
        • Diagnosis
        • Treatment Selection
        • Monitoring
      • North America Cardiac Biomarkers Market, By Indication,
        • Oncology
          • By Type
            • Breast Cancer
            • Lung Cancer
            • Colon Cancer
            • Others
          • By Circulating Biomarkers
            • Circulating Tumor Cells (CTCs)
            • Circulating Cell-free DNA (cfDNA)
            • Extracellular Vesicles (EVs)
            • Other Circulating Biomarkers
        • Neurology
        • Diabetes
        • Autoimmune Diseases
        • Cardiology
        • Others
      • U.S.
        • U.S. Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • U.S. Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Canada
        • Canada Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Canada Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
    • Europe
      • Europe Cardiac Biomarkers Market, By Application
        • Early Detection/Screening
        • Diagnosis
        • Treatment Selection
        • Monitoring
      • Europe Cardiac Biomarkers Market, By Indication,
        • Oncology
          • By Type
            • Breast Cancer
            • Lung Cancer
            • Colon Cancer
            • Others
          • By Circulating Biomarkers
            • Circulating Tumor Cells (CTCs)
            • Circulating Cell-free DNA (cfDNA)
            • Extracellular Vesicles (EVs)
            • Other Circulating Biomarkers
        • Neurology
        • Diabetes
        • Autoimmune Diseases
        • Cardiology
        • Others
      • U.K.
        • U.K. Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • U.K. Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
          •  
      • Germany
        • Germany Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Germany Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • France
        • France Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • France Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Italy
        • Italy Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Italy Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Spain
        • Spain Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Spain Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
    • Asia Pacific
      • Asia Pacific Cardiac Biomarkers Market, By Application
        • Early Detection/Screening
        • Diagnosis
        • Treatment Selection
        • Monitoring
      • Asia Pacific Cardiac Biomarkers Market, By Indication,
        • Oncology
          • By Type
            • Breast Cancer
            • Lung Cancer
            • Colon Cancer
            • Others
          • By Circulating Biomarkers
            • Circulating Tumor Cells (CTCs)
            • Circulating Cell-free DNA (cfDNA)
            • Extracellular Vesicles (EVs)
            • Other Circulating Biomarkers
        • Neurology
        • Diabetes
        • Autoimmune Diseases
        • Cardiology
        • Others
      • Japan
        • Japan Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Japan Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • China
        • China Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • China Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • India
        • India Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • India Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Australia
        • Australia Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Australia Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • South Korea
        • South Korea Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • South Korea Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
    • Latin America
      • Latin America Cardiac Biomarkers Market, By Application
        • Early Detection/Screening
        • Diagnosis
        • Treatment Selection
        • Monitoring
      • Latin America Cardiac Biomarkers Market, By Indication,
        • Oncology
          • By Type
            • Breast Cancer
            • Lung Cancer
            • Colon Cancer
            • Others
          • By Circulating Biomarkers
            • Circulating Tumor Cells (CTCs)
            • Circulating Cell-free DNA (cfDNA)
            • Extracellular Vesicles (EVs)
            • Other Circulating Biomarkers
        • Neurology
        • Diabetes
        • Autoimmune Diseases
        • Cardiology
        • Others
      • Brazil
        • Brazil Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Brazil Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Mexico
        • Mexico Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Mexico Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Argentina
        • Argentina Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Argentina Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
    • MEA
      • MEA Cardiac Biomarkers Market, By Application
        • Early Detection/Screening
        • Diagnosis
        • Treatment Selection
        • Monitoring
      • MEA Cardiac Biomarkers Market, By Indication,
        • Oncology
          • By Type
            • Breast Cancer
            • Lung Cancer
            • Colon Cancer
            • Others
          • By Circulating Biomarkers
            • Circulating Tumor Cells (CTCs)
            • Circulating Cell-free DNA (cfDNA)
            • Extracellular Vesicles (EVs)
            • Other Circulating Biomarkers
        • Neurology
        • Diabetes
        • Autoimmune Diseases
        • Cardiology
        • Others
      • South Africa
        • South Africa Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • South Africa Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • Saudi Arabia
        • Saudi Arabia Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • Saudi Arabia Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others
      • UAE
        • UAE Cardiac Biomarkers Market, By Application
          • Early Detection/Screening
          • Diagnosis
          • Treatment Selection
          • Monitoring
        • UAE Cardiac Biomarkers Market, By Indication,
          • Oncology
            • By Type
              • Breast Cancer
              • Lung Cancer
              • Colon Cancer
              • Others
            • By Circulating Biomarkers
              • Circulating Tumor Cells (CTCs)
              • Circulating Cell-free DNA (cfDNA)
              • Extracellular Vesicles (EVs)
              • Other Circulating Biomarkers
          • Neurology
          • Diabetes
          • Autoimmune Diseases
          • Cardiology
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon